Company: LNAI
Filing Date: 2025-04-18
Form Type: 8-K
Source: 0001731122-25-000592
Chunk: 0

Company: Lunai Bioworks Inc.
Filing Date: 2025-04-18
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing

On April 14, 2025, Renovaro Inc.
(the “ Company”) received a deficiency notice from The Nasdaq Stock Market (“ Nasdaq”) informing the
Company that its common stock, par value $0.0001 per share (the “ Common Stock”), fails to comply with the $1 minimum
bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) based upon the closing bid
price of the Common Stock for the 30 consecutive business days prior to the date of the notice from Nasdaq.

Nasdaq’s notice has no immediate
effect on the listing of the Common Stock on The Nasdaq Capital Market and, at this time, the Common Stock will continue to trade on The
Nasdaq Capital Market under the symbol “ RENB”. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided
an initial compliance period of 180 calendar days, or until October 13, 2025, to regain compliance with the minimum bid price requirement.
To regain compliance, the closing bid price of the Common Stock must meet or exceed $1.00 per share for a minimum of ten consecutive business
days prior to October 13, 2025.

If the Company is unable to regain
compliance by October 13, 2025, the Company may be eligible for an additional 180 calendar day compliance period to demonstrate compliance
with the minimum bid price requirement. To qualify, the Company will be required to meet the continued listing requirement for market
value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the minimum
bid price requirement, and will need to provide written notice to Nasdaq of its intention to cure the deficiency during the second compliance
period. If the Company does not qualify for the second compliance period or fails to regain compliance during the second 180 calendar
day period, Nasdaq will notify the Company of its determination to delist the Common Stock, at which point the Company would have an opportunity
to appeal the delisting determination to a Hearings Panel.

The Company intends to monitor
the closing bid price of its Common Stock and is considering its options to regain compliance with the minimum bid price requirement under
the Nasdaq Listing Rules.

SIGNATURES